The Ministry of Health of-the-the Democratic Republic of Congo (DRC) today announced a randomized control trial That Has begun to Evaluate the-effectiveness and safety of drugs Used in-the-TREATMENT of Ebola patient. The the trial-the first-ever multi-drug trial for an Ebola TREATMENT. Will it form part of a multi-Outbreak, a multi-country study by That Was Agreed to partners Under a World Health Organization (WHO) initiative.
"Whiles remaini Our focus on Outbreak Print Bringing to an end, the-the-launch of a randomized control trial in the DRC finally Towards an important step Finding an Ebola TREATMENT That Will Save lives," said WHO Director-General Dr Tedros Adhanom Ghebreyesus. "Until now, patient Have Been treated Under a compassionate use technologies protocol, With drugs That showed promise and thought a Good safety profile in laboratory conditions In. The giant step DRC the-taking now Will bring CLARITY about What best works, and save MANY lives in Years to come. We hope to one day say That death-the suffering and the Ebola From behind us. "
Until now, over 160 patient treated Have Been With an investigational therapeutics Under Ethical framework developed by WHO, in Consultation With Experts-the-field and in-the DRC, called the-Monitored Emergency Investigational Use of Unregistered and Intervention (MEUR). The MEUR protocol wasnt Designed to Evaluate the-drugs. Now That protocols are in place for trials, patient That Will Be Offered Treatment Under the framework wherein the-facilities-the trial Has Started. In others, compassionate use technologies Will Continue up to the-time whens They join the randomization. Patients will not noticeably BE treated differently From before, though-the-TREATMENT Receives They Will Be DECIDED by random allocation. The data gathered and standardized Will Become Will Be Useful for drawing Conclusions about safety and Efficacy of-the-the drugs.
"Our country struck the Ebola Outbreak With too OFTEN, Which Means ALSO we have unique expertise in combatting it," said Dr. Olly ilunga, Minister of Health of-the DRC. "These trials That Will contribute to building Knowledge, whiles we Continue on to RESPOND Every front to bring to an end-the current Outbreak."
In October, WHO convened a meeting of International Organization, United Nations partners, Countries at risk of Ebola, drug Manufacturers and others to agree on a framework to Continue Next-the Ebola Outbreak in trials, whenever and wherever That is. Over time, Print Will lead to an accumulation of evidence That Will Help to score Conclusions robust across-the CURRENTLY Available Outbreak about drugs, and new ones ANY That May come alongs.
At the heart of the-long-term plan ALWAYS And The current trial-the goal to ensure the patient That With Ebola are treated and their Communities With RESPECT and fairness. All patient shouldnt provided BE With The highest level of care and have access to-the PROMISING must MEDICATION.
The current trial the Coordinated by WHO, and led and sponsored by the-DRC's National Institute for Biomedical Research (INRB), in With partnership-the DRC Ministry of Health, The National Institute of Allergy and Infectious Diseases (NIAID) Which the part of the-United States' National Institutes of Health, The Alliance for International Medical Action (ALIMA) and Other Organizations.
(With Inputs From South African Government Press Release)